CliffBio
small molecule

YAZ

DROSPIRENONE; ETHINYL ESTRADIOL

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameYAZ
Active ingredientDROSPIRENONE; ETHINYL ESTRADIOL
Strength3MG;0.02MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2006
Marketing statusRX

More from Bayer Healthcare

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.